May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...
May 10, 2026 — WhiteSwell has announced primary results from the DELTA-HF feasibility clinical trial evaluating the eLym ...
May 19, 2026 — GE HealthCare recently announced it is making more than 20 hours of healthcare AI training available at ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
May 18, 2026 — Fujifilm Healthcare Americas Corp. has launched the EB-710US Ultrasound Bronchoscope, an endobronchial ...
May 18, 2026 — AstraZeneca’s Baxfendy (baxdrostat) has been approved in the U.S. as a first-in-class aldosterone ...
May 1, 2026 — Philips has received FDA 510(k) clearance for its Smart Fit TorsoCardiac 1.5T coil, a lightweight and ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
May 13, 2026 — According to a recently released report, the global cath lab services market was valued at $46.0 billion ...
Editor's Note: This is Part Three of a three-part series highlighting several of the presentations from the American ...
May 1, 2026 — On May 14, Cleerly and interventional cardiologist Neerav Sheth, MD, will present a free webinar on ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
May 12, 2026 — Johnson & Johnson has launched its Shockwave C2 Aero Coronary IVL catheter designed for improved ...
May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...
May 7, 2026 — AccurKardia, a provider of ECG-based diagnostics technology, recently announced that AK+ Guard has been ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
May 1, 2026 — Echo IQ recently announced it has deployed its AI-based decision support software for the assessment of ...
May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...
May 1, 2026 — Retia Medical recently announced the first public presentation of results from its non-invasive cardiac ...
May 21, 2026
